Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Instructions to Upgrade the Mechanical Highlights of Your Shrewd Bed for a Superior Night's Rest - 2Climbing Mount Everest: An Individual Victory
- 3New Year's Eve Live: Nashville's Big Bash: How to watch the star-studded country music special live
- 4Tatiana Schlossberg, JFK's granddaughter, dies at 35 after terminal cancer diagnosis
- 5Flourishing in Retirement: Individual Accounts of Post-Vocation Satisfaction
- Vote in favor of your favored spot to peruse
- Car Investigation: A Survey of \Past the Outside\ Car
- Peruvian ex-President Martin Vizcarra sentenced to 14 years in prison
- Barry Manilow reveals lung cancer diagnosis and plans to undergo surgery: 'It's pure luck' it was 'found so early'
- EU delays signing of Mercosur free trade deal
- My Enterprising Excursion: Building a Startup
- The most effective method to Connect Successfully with Teachers in a Web based Setting
- Get To Be familiar with The Historical backdrop Of Western Medication
- Winter storms blanket the East, while the U.S. West is wondering: Where’s the snow?
